Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: May 2014

VistaGen Therapeutics, Inc. (VSTA) Approved to Expand Intellectual Property Portfolio for Stem Cell Technology Platform

Posted on May 7, 2014 by MissionIR

VistaGen Therapeutics is a biotechnology company whose focus is on applying pluripotent stem cell technology for drug rescue and regenerative medicine. The company, which is based out of San Francisco, has been in the business of human pluripotent stem cell … Continue reading →

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment

Continental Stock Transfer & Trust Company Ensures Accurate Stock Plan Administration

Posted on May 6, 2014 by MissionIR

Continental Stock Transfer & Trust Company has long been known for offering flexible and comprehensive stock management services to public companies, including smaller and midsize emerging and growth companies. Among their many services is stock plan administration, providing first-class attention … Continue reading →

Posted in Small Cap News | Leave a comment

Methes Energies International Ltd. (MEIL) Builds Reputation for Innovative Biodiesel Technology, Powerful Client Support

Posted on May 5, 2014 by MissionIR

Methes Energies founders John Loewen and Nicholas Ng once shared a vision to find a small-scale solution to commercially produce biodiesel, and more than 10 years ago set out to find equipment capable of fitting this bill. During their explorative … Continue reading →

Posted in Methes Energies International MEIL | Leave a comment

Stellar Biotechnologies, Inc. (SBOTF) Launches New Corporate Website

Posted on May 2, 2014 by MissionIR

Today before the opening bell, Stellar Biotechnologies unveiled its new corporate website (www.stellarbiotech.com). The new website includes streamlined, up-to-date content on Stellar Biotechnologies’ Keyhole Limpet Hemocyanin (KHL) products, breakthroughs in aquaculture science, and strategic expansion of its immunotherapy program. Stellar … Continue reading →

Posted in Small Cap News | Leave a comment

LabStyle Innovations Corp. (DRIO) Receives Notice of Allowance for Patent Relating to Dario™ Glucose Monitoring Device

Posted on May 1, 2014 by MissionIR

LabStyle Innovations, developer of patent-pending diabetes management solution, has received a Notice of Allowance from the U.S. Patent and Trademark Office for core patent claims covering the company’s personalized blood glucose monitoring device. The company’s patent pending invention, entitled “FLUID … Continue reading →

Posted in Small Cap News | Leave a comment